Butler Memorial Hospital Wins HeartFlow CT Quality Award

BHS Radiology & Diagnostic Imaging and BHS Cardiology Team Members
Front row (left to right): Tabitha Donaldson, Dr. Brian Carey, Darla Culbertson, Dr. Rekha Pinto
Back row (left to right): Brett Yargar, Tara McHenry, Jeffery Mechling, Amber Ripper, Robin Stiner

More than 160 patients have received a HeartFlow Analysis at Butler Memorial Hospital since the program’s inception in 2021.

Butler, PA – April 6, 2023 – Butler Memorial Hospital’s radiology & diagnostic imaging department and cardiology team were recently awarded the HeartFlow CT Quality Award in the 4nd quarter of 2022. Recipients of the HeartFlow CT Quality Award are determined based on metrics assessing the quality and adoption of a medical center’s cardiovascular imaging program. Recipients of the award are in the top 22% of global medical centers providing patients with a better pathway for identifying and understanding their heart health by utilizing coronary CT and the HeartFlow Analysis. The HeartFlow Analysis is a first-of-its-kind non-invasive technology to aid physicians in the diagnoses of coronary artery disease (CAD), the most common form of heart disease.

“The CCTA + FFR-CT pathway at BHS aims to bring to the community, the latest advances in the detection of CAD,” said Rekha Pinto, MD, BHS Cardiology. “Our focus is to provide the best quality of care to achieve the best health outcomes for our patients.”

The HeartFlow Analysis takes data from a patient’s non-invasive coronary CTA and leverages algorithms trained using deep learning (a form of AI) and highly trained analysts to create a personalized, digital 3D model of the patient’s coronary arteries. It then uses powerful computer algorithms to simulate blood flow and assess the impact of blockages on blood flow to the heart. Within hours, the HeartFlow Analysis is provided to the patient’s physician via a secure web interface, and provides information on the extent of a patient’s arterial blockage and the impact the blockage has on blood flow to the heart.

The HeartFlow Analysis has been used for more than 170,000 patients with suspected heart disease and offers the highest diagnostic accuracy available from a non-invasive test. Additionally, in clinical trials, using the HeartFlow Analysis helped identify which patients do and do not need invasive treatment. The use of the HeartFlow Analysis also reduced the cost of care by 26% compared to usual care. To learn more about the cardiology services at BHS, visit www.BHSCardiology.org or call 866-620-6761.